238
Participants
Start Date
March 31, 2013
Primary Completion Date
August 31, 2015
Study Completion Date
August 31, 2015
Paclitaxel
Oral administration on day 1,8,15 of 4-week cycle until progression, unacceptable toxicity or withdrawal of informed concent
Paclitaxel
Premedication, IV infusion on day 1 of 3-week cycle until progression, unacceptable toxicity or withdrawal of informed concent
Inje University Haeundae Paik Hospital, Busan
Kyungpook National University Medical Center, Daegu
National Cancer Center, Goyang-si
Chonnam National University Hwasun Hospital, Jungnam
Seoul National University Bundang Hospital, Seongnam-si
Yonsei University Severance Hospital, Seoul
Samsung Medical Center, Seoul
Yonsei University Gangnam Severance Hospital, Seoul
Seoul St. Mary's Hospital, Seoul
Asan Medical Center, University of Ulsan College of Medicine, Seoul
Asan Medical Center, Seoul
Korea University Guro Hospital, Seoul
Ajou University Hospital, Suwon
Lead Sponsor
Daehwa Pharmaceutical Co., Ltd.
INDUSTRY